eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Treatment of high risk renal tumors

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
  3. Intervention
  4. Intervention
    Doxorubicin hydrochloride
  5. Intervention
  6. Intervention
    Irinotecan hydrochloride
  7. Intervention
    Vincristine sulfate
  8. Intervention
  9. Intervention
    Conventional surgery
  10. Additional Topic(s)
    Antineoplastic Combined Chemotherapy Protocols
  11. Additional Topic(s)
  12. Resource Description
    Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving combination chemotherapy together with radiation therapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. This phase II trial is studying how well combination chemotherapy, radiation therapy, and/or surgery work in treating patients with high-risk kidney tumors.
  13. Contact
    Berenberg, Jeffrey
  14. PI
    Wilkinson, Robert, M.D.
  15. Topic
    kidney cancer
  16. Study Population
    Persons 30 years old or younger who meet other tumor-related criteria.
  17. Funded by
    Children's Oncology Group
  18. Phase
    Phase 2 clinical trial
  19. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016